openPR Logo
Press release

Antisense & RNAi Therapeutics Global Market By Manufacturers, Technology, Application, Product Type, Regions, End-Users, Growth Analysis And Forecast To 2031

11-28-2022 05:23 AM CET | Health & Medicine

Press release from: The Business research company

Antisense & RNAi Therapeutics Global Market By Manufacturers,

The global antisense & RNAi therapeutics market report by the business research company identifies the rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is projected to contribute to the demand for the antisense & RNAi therapeutics market. Gene suppression approaches including RNA interference and antisense oligonucleotides are used for the treatment of various neurodegenerative conditions by repairing mutant genes. According to the National Institute of Environmental Health Sciences, Alzheimer's disease and Parkinson's disease are the most common neurodegenerative diseases affecting millions of people globally. In the USA, around 930,000 people had Parkinson's disease by the end of 2020. Furthermore, according to the World Health Organization (WHO), infectious diseases are a major concern and dominated the WHO's list of 2019 health threats ranging from various climate change issues to inadequate healthcare facilities. Hence, the growing prevalence of several neurodegenerative diseases and infectious diseases is expected to drive the growth of the antisense & RNAi therapeutics market.

The global antisense & RNAI therapeutics market is expected to grow from $1.32 billion in 2021 to $1.42 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The antisense & RNAi therapeutics market is expected to reach $2.14 billion in 2026 at a CAGR of 10.8%.

Purchase The Antisense & RNAi Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the antisense & RNAi therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A, Acuitas Therapeutics and Antisense Therapeutics Ltd.

The global antisense & RNAi therapeutics market is segmented -
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other.

Request A Sample Of The Antisense & RNAi
Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp

The Antisense & RNAi Therapeutics Market Report Contents Include
1. Executive Summary
2. Antisense & RNAi Therapeutics Market Characteristics
3. Antisense & RNAi Therapeutics Market Trends And Strategies
4. Antisense & RNAi Therapeutics Market - Macro Economic Scenario
5. Antisense & RNAi Therapeutics Market Size And Growth
.....
27. Antisense & RNAi Therapeutics Market Competitive Landscape And Company Profiles
28. Antisense & RNAi Therapeutics Pipeline Analysis
29. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market
30. Antisense & RNAi Therapeutics Market Future Outlook and Potential Analysis
31. Appendix

This report covers the trends and market dynamics of the antisense & RNAi therapeutics market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antisense & RNAi Therapeutics Global Market By Manufacturers, Technology, Application, Product Type, Regions, End-Users, Growth Analysis And Forecast To 2031 here

News-ID: 2822928 • Views: 315

More Releases from The Business research company

Global Yarn, Fiber And Thread Market 2023-2032 : Demand, Trend, Segmentation, Fo …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the Yarn, Fiber And Thread market report by The Business Research Company, the growth in the yarn, fibre, and thread manufacturing market is due to emerging market growth, rising disposable income, and technology development. The global yarn, fiber and thread market size will grow from $102.97
Woodworking Machinery Global Market 2023 : Industry Analysis, Trends, Segmentati …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the Woodworking Machinery market report by The Business Research Company, the increasing adoption of the automated woodworking machinery market is expected to propel the growth of the woodworking machinery market in the forecast period. The global woodworking machinery market size is expected to grow from $28.18
(2023-2032) Wind Turbine Global Market Trends And Forecast Report | By Types, Ap …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the Wind Turbine market report by The Business Research Company, Increasing demand for renewable energy sources is contributing to the growth of the wind turbine market. The global wind turbine market grew from $79.13 billion in 2022 to $78.43 billion in 2023 at a compound annual
Uranium Ore Market 2023 Size, Industry Overview, Demand Factors And Forecast To …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 As per the uranium ore market report by The Business Research Company, The use of autonomous hauling systems trucks in the mining industry is significantly enhancing production efficiency and reducing turnaround time. Autonomous haulage systems control and track mining vehicle movements, and coordinate and autonomously drives off-highway

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and